A venture capital firm founded in 2014 is managing $150 million fund on behalf of a large, not-for-profit health system in the United States. The firm has closed a second $150 million venture and growth equity fund.
As of 2025, the firm has initially closed a third fund and spun out as an independent venture capital firm. The firm has committed $150M, and the firm will seek to have a final close later in the year with additional LPs. Typical equity allocations had ranged from $8-15 million over the life of a company. The firm is looking primarily for opportunities across the US, and the firm would consider international companies with strong US advocacy and technology that can be deployed to the US market.
The firm is looking for innovative medical technologies that are in line with the organization’s mission, improve quality and convenience, lower cost and improve health outcomes. Examples may include patient management systems for healthcare providers, home care systems, or monitoring devices for chronic disease management. The firm typically works with mature companies with revenue, consumer traction, or some validation on their technology.
The firm is looking for solid management teams that show track records of success. The firm provides healthcare system expertise to portfolio companies to refine existing solutions, while expanding their adoption within and beyond its healthcare system. Providence Ventures is open to investing as a lead or co-investing along a syndicate.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment